Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury

NCT07086755 is registered in ClinicalTrials.gov with Paul Potnuru as lead sponsor.

NCT NCT07086755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07086755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury
Lead sponsor
Paul Potnuru
Phase
Phase 2/3
Overall status
Recruiting
Start date
October 23, 2025
Completion date
May 31, 2031
Enrollment
1,100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonintubated acute respiratory distress syndrome (ards), pathogen-associated lung injury